Clinical Trials on Exercise Intervention in Russian Federation
Total 9 results
-
Tomsk National Research Medical Center of the Russian...CompletedST Elevation Myocardial Infarction | Percutaneous Coronary Intervention | No-Reflow PhenomenonRussian Federation
-
Research Institute for Complex Problems of Cardiovascular...UnknownHeart Failure | Sarcopenia | Peripheral Artery Disease | Exercise IntoleranceRussian Federation
-
AstraZenecaRecruiting
-
I.M. Sechenov First Moscow State Medical UniversityCompletedQuality of Life | Metabolic Disturbance | Exercise Tolerance | Hypoxia, AltitudeRussian Federation
-
I.M. Sechenov First Moscow State Medical UniversityEnrolling by invitationCOVID-19 | Quality of Life | Oxygen Consumption | Diastolic Dysfunction | Endothelial Function | Exercise ToleranceRussian Federation
-
I.M. Sechenov First Moscow State Medical UniversityRecruitingCOVID-19 | Quality of Life | Hypertension | Arrhythmia | Chronic Heart Failure | Endothelial Dysfunction | Conduct Disorder | Oxygen Consumption | Diastolic Dysfunction | Chronic Coronary Syndrome | Exercise ToleranceRussian Federation
-
Boehringer IngelheimPfizerCompletedPulmonary Disease, Chronic Obstructive | ExerciseUnited States, Argentina, Brazil, Canada, Germany, Italy, Portugal, Russian Federation, Spain, Taiwan, Ukraine
-
Janssen Scientific Affairs, LLCBayerCompletedAtrial Fibrillation | Percutaneous Coronary InterventionUnited States, France, Poland, Ukraine, United Kingdom, Belgium, Germany, Taiwan, Argentina, Mexico, Bulgaria, Malaysia, Romania, Russian Federation, South Africa, Turkey, Korea, Republic of, Australia, Canada, Netherlands, Denmark and more
-
Boehringer IngelheimCompletedAtrial Fibrillation | Percutaneous Coronary InterventionCanada, United States, Spain, Korea, Republic of, Australia, Germany, Taiwan, Hong Kong, Thailand, United Kingdom, Turkey, Netherlands, Ireland, Hungary, Croatia, Colombia, Israel, Singapore, Italy, New Zealand, Greece, Mexico, Norway, Swed... and more